Receive the latest news 
straight to your inbox
Learn more
We are the Cystic Fibrosis AMR Syndicate
On this page:

Bridging the translational gap to accelerate antimicrobial and diagnostic innovation for CF lung infections and beyond.

Cystic Fibrosis Nebuliser

Who we are

We are on a mission to accelerate the development of new antimicrobials and diagnostics to improve the lives of people with cystic fibrosis (CF) and others living with chronic infection.

We connect innovators in academia and industry to a uniquely coordinated cross-sector community, providing the expertise, resources, and support needed to navigate complex challenges and translate discoveries into real-world solutions.

Our research agenda has been informed by extensive efforts to understand the research landscape and the needs of the CF infection research community.

Learn more about us
bg-pattern
Dr Paula Sommer

“People living with CF are particularly vulnerable to antimicrobial resistance. New antimicrobials that target infections caused by bugs commonly associated with lung infections in CF are urgently needed.”

Dr Paula Sommer, Head of Research at Cystic Fibrosis Trust